Form 483

Lambda SpA Form 483, 2013-05-17

FDA issued a Form 483 to Lambda SpA on 2013-05-17 with 6 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health6 observations

Lambda SpA · Brendola, Italy · Issued May 17, 2013

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 May 2013
21 CFR 820.30(e)

Design review - Lack of or inadequate procedures

Cited by Amy M Cramer

17 May 2013
21 CFR 820.80(d)

Lack of or inadequate final acceptance procedures

Cited by Amy M Cramer

17 May 2013
21 CFR 820.184

Lack of or inadequate DHR procedures

Cited by Amy M Cramer

17 May 2013
21 CFR 1002.10

Failure to submit, distinct marking

Cited by Amy M Cramer

17 May 2013
21 CFR 1002.13

Failure to submit

Cited by Amy M Cramer

Inspected site

LSLambda SpABrendola, Italy

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1002.10Cited across public-safe Form 483 observations1x
21 CFR 1002.13Cited across public-safe Form 483 observations1x
21 CFR 1040.10(h)(2)(i)Cited across public-safe Form 483 observations1x
21 CFR 820.184Cited across public-safe Form 483 observations1x
21 CFR 820.30(e)Cited across public-safe Form 483 observations1x
21 CFR 820.80(d)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere